Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Jubilant Pharmova Ltd - Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Download < Back
19 Apr 2021
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a communication pertaining to development of a novel oral formulation of Remdesivir with successful completion of safety and pharmacokinetic/absorption studies.&lt;BR&gt; &lt;BR&gt; We request you to take the same on record.&lt;BR&gt;
View all announcements for Jubilant Pharmova Ltd Source: BSE India

Mutual Fund Selector

Find the fund that is right for you